% | $
Quotes you view appear here for quick access.

Corrections Corporation of America Message Board

fatty_mcknuckles 2 posts  |  Last Activity: Jul 27, 2015 12:30 PM Member since: Jan 8, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to


    by jpust47573 Jul 27, 2015 9:50 AM
    fatty_mcknuckles fatty_mcknuckles Jul 27, 2015 12:30 PM Flag

    This is odd. Stock has shot up, so it's understandable if an analyst says they think it's now overvalued. But MS underwrote the recent secondary at $120. Given RARE is buyout candidate, this looks a bit suspicious.

    Also, seems a bit of an overreaction to an analyst's opinion.

  • fatty_mcknuckles by fatty_mcknuckles Jun 12, 2015 11:40 AM Flag

    Glad they raised funds - always a good idea for a biotech to snag money while it's available. But not a fan of issuing more warrants. Company's capital structure is getting messy. And warrants may place a ceiling on stock, as it makes it less risky to short. If the drugs pan out, this won't matter. But let's hope no more warrants in future.

29.43+0.10(+0.34%)10:15 AMEDT